Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homescience news

      science news

      Merck Stock Went Down Even After the Company Reported Its Q4 Results
      Investing News

      Merck Stock Went Down Even After the Company Reported Its Q4 Results

      February 1, 2023
      Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer
      Investing News

      Merck Stock Rose After Keytruda Met the Phase 3 Trial Survival Objective in Biliary Tract Cancer

      January 25, 2023
      Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study
      Investing News

      Moderna Stock Gains on Positive Data From the Phase III RSV Jab Study

      January 18, 2023
      Abbvie Stock Price Rose After the Company and Lilly Pulled Out of a Medicine Pricing Agreement in the UK
      Investing News

      Abbvie Stock Price Rose After the Company and Lilly Pulled Out of a Medicine Pricing Agreement in the UK

      January 16, 2023
      Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S
      Investing News

      Moderna Stock Drops as Secures Ebola Vaccine Contract With the U.S

      January 11, 2023
      Pfizer Stock Slightly Drops as It Confirms It Isn’t in Talks With the Chinese Government on Generic Paxlovid, Reuters
      Investing News

      Pfizer Stock Slightly Drops as It Confirms It Isn’t in Talks With the Chinese Government on Generic Paxlovid, Reuters

      January 11, 2023
      Moderna Stock Rises on Positive Business Outlook
      Investing News

      Moderna Stock Rises on Positive Business Outlook

      January 10, 2023
      Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022
      Investing News

      Moderna Stock Surged as It Expects COVID Vaccine Sales of $5 Billion in 2023, Down From $18 Billion in 2022

      January 9, 2023
      Pfizer Stock up as China Negotiates License for the COVID Medication Paxlovid 
      Investing News

      Pfizer Stock up as China Negotiates License for the COVID Medication Paxlovid 

      January 6, 2023
      AbbVie stock up in wake of partnership with Immunome 
      Investing News

      AbbVie stock up in wake of partnership with Immunome 

      January 6, 2023
      « 1 2 3 4 5 … 16 »

       

      LATEST NEWS

      • Investing News HP to Cut 6,000 Jobs Amid Restructuring
      • Investing News Dell’s Q3 2026 Earnings Analysis
      • Investing News Workday Q3 Earnings Report 2026 Insights
      • Investing News Alibaba’s AI Boosts Cloud Sales
      • Investing News Best Buy Q3 2026 Earnings Report Insights

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025